0001708138-20-000068.txt : 20200610 0001708138-20-000068.hdr.sgml : 20200610 20200610160445 ACCESSION NUMBER: 0001708138-20-000068 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200608 FILED AS OF DATE: 20200610 DATE AS OF CHANGE: 20200610 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Landry Robert E CENTRAL INDEX KEY: 0001585160 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 20954719 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-06-08 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001585160 Landry Robert E 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 EVP Finance CFO Common Stock 2020-06-08 4 M 0 3500 272.7 A 27873 D Common Stock 2020-06-08 4 F 0 2536 592.43 D 25337 D Common Stock 2020-06-08 4 M 0 3500 272.7 A 28837 D Common Stock 2020-06-08 4 F 0 2536 592.43 D 26301 D Common Stock 2020-06-08 4 M 0 2500 272.7 A 28801 D Common Stock 2020-06-08 4 F 0 1811 592.4 D 26990 D Common Stock 2020-06-08 4 M 0 2250 272.7 A 29240 D Common Stock 2020-06-08 4 F 0 1630 592.43 D 27610 D Common Stock 2020-06-08 4 M 0 2250 272.7 A 29860 D Common Stock 2020-06-08 4 F 0 1630 592.43 D 28230 D Common Stock 2020-06-08 4 M 0 1500 272.7 A 29730 D Common Stock 2020-06-08 4 F 0 1086 592.43 D 28644 D Common Stock 2020-06-09 4 S 0 110 602.38 D 28534 D Common Stock 2020-06-09 4 S 0 131 603.68 D 28403 D Common Stock 2020-06-09 4 S 0 50 604.14 D 28353 D Common Stock 2020-06-09 4 S 0 289 605.14 D 28064 D Common Stock 2020-06-09 4 S 0 353 606.79 D 27711 D Common Stock 2020-06-09 4 S 0 619 607.47 D 27092 D Common Stock 2020-06-09 4 S 0 1511 608.5 D 25581 D Common Stock 2020-06-09 4 S 0 681 609.53 D 24900 D Common Stock 2020-06-09 4 S 0 527 610.25 D 24373 D Common Stock 200 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 272.7 2020-06-08 4 M 0 3500 0.0 D 2023-09-09 Common Stock 3500 15500 D Non-Qualified Stock Option (right to buy) 272.7 2020-06-08 4 M 0 3500 0.0 D 2023-09-09 Common Stock 3500 12000 D Non-Qualified Stock Option (right to buy) 272.7 2020-06-08 4 M 0 2500 0.0 D 2023-09-09 Common Stock 2500 9500 D Non-Qualified Stock Option (right to buy) 272.7 2020-06-08 4 M 0 2250 0.0 D 2023-09-09 Common Stock 2250 7250 D Non-Qualified Stock Option (right to buy) 272.7 2020-06-08 4 M 0 2250 0.0 D 2023-09-09 Common Stock 2250 5000 D Non-Qualified Stock Option (right to buy) 272.7 2020-06-08 4 M 0 1500 0.0 D 2023-09-09 Common Stock 1500 3500 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 110 shares of Company stock on June 9, 2020 at prices ranging from $602.35 to $602.41. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 9, 2020 at each separate price. Represents volume-weighted average price of sales of 131 shares of Company stock on June 9, 2020 at prices ranging from $603.33 to $603.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 9, 2020 at each separate price. Represents volume-weighted average price of sales of 289 shares of Company stock on June 9, 2020 at prices ranging from $605.07 to $605.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 9, 2020 at each separate price. Represents volume-weighted average price of sales of 353 shares of Company stock on June 9, 2020 at prices ranging from $606.46 to $606.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 9, 2020 at each separate price. Represents volume-weighted average price of sales of 619 shares of Company stock on June 9, 2020 at prices ranging from $607.00 to $607.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 9, 2020 at each separate price. Represents volume-weighted average price of sales of 1,511 shares of Company stock on June 9, 2020 at prices ranging from $608.14 to $608.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 9, 2020 at each separate price. Represents volume-weighted average price of sales of 681 shares of Company stock on June 9, 2020 at prices ranging from $609.41 to $609.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 9, 2020 at each separate price. Represents volume-weighted average price of sales of 527 shares of Company stock on June 9, 2020 at prices ranging from $610.00 to $610.54. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 9, 2020 at each separate price. The stock option award vests in four equal annual installments, commencing one year after the date of grant. /s/**Robert E. Landry 2020-06-10